{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acquired-central-diabetes-insipidus","columns":[{"gene":"","key":"population-cf4087ed9dadd9d80601","label":"Acquired arginine vasopressin deficiency","mondoId":"MONDO:0019846","onsetQualifier":null,"originColumnKey":"MONDO:0019846/ORPHA:95626","originalViews":[{"key":"MONDO:0019846/ORPHA:95626","label":"Acquired arginine vasopressin deficiency","scopeLabel":"ORPHA:95626","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["061a2b0f3afa8e5d7676794486916ff1cb8fa41721f347ac23c7e5d6ce477c1e","14f6049c0cfa44b67580a89a0fb55a258cc4e7818b84ee4115fe560ec53b25a5","206870b13eecdc5bb895b60a136b6dd82220d91d83723199f39c33d718207254","39629a9570fed387d79afe4c863e70d4c60b219bb41f5496d5817aa0c780f1d2"],"recordQualifiers":{},"scopeLabel":"ORPHA:95626","sourceIds":["ORPHA:95626"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-cf4087ed9dadd9d80601"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000873","HP:0100515","HP:0001959","HP:0001824"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":4,"sourceGroups":{"orphanet":4}},"features":[{"hpoId":"HP:0000873","label":"Diabetes insipidus","primary":true},{"hpoId":"HP:0100515","label":"Pollakisuria","primary":true},{"hpoId":"HP:0001959","label":"Polydipsia","primary":true},{"hpoId":"HP:0001824","label":"Weight loss","primary":true}],"ledeHtml":"Acquired central diabetes insipidus (acquired CDI) is a subtype of central diabetes insipidus (CDI), characterized by polyuria and polydipsia, due to an idiopathic or secondary decrease in vasopressin (AVP) production.","mondoId":"MONDO:0019846","node":{"canonicalSlug":"acquired-central-diabetes-insipidus","comparisons":[{"documentSha256":"30746a5f8fa82c022055351813293fe90a1a247760d69f91c20adbfca5572519","key":"legacy-acquired-central-diabetes-insipidus","kind":"legacy","label":"acquired central diabetes insipidus","memberIds":["MONDO:0019846"],"mondoId":"MONDO:0019846","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/acquired-central-diabetes-insipidus.30746a5f8fa82c022055351813293fe90a1a247760d69f91c20adbfca5572519.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"acquired central diabetes insipidus","paragraphs":["Acquired central diabetes insipidus (acquired CDI) is a subtype of central diabetes insipidus (CDI), characterized by polyuria and polydipsia, due to an idiopathic or secondary decrease in vasopressin (AVP) production."],"scope":"exact","source":"MONDO","upstream":"Orphanet:95626","url":"https://monarchinitiative.org/MONDO:0019846"},"ownColumnKeys":["population-cf4087ed9dadd9d80601"],"publication":"published","relationships":[{"kind":"parent","label":"central diabetes insipidus","mondoId":"MONDO:0015790","slug":"central-diabetes-insipidus"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/19291"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"061a2b0f3afa8e5d7676794486916ff1cb8fa41721f347ac23c7e5d6ce477c1e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:95626","disease_name":"Acquired arginine vasopressin deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000873","is_excluded":false,"label":"Diabetes insipidus","onset_id":null,"reference":"ORPHA:95626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"14f6049c0cfa44b67580a89a0fb55a258cc4e7818b84ee4115fe560ec53b25a5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:95626","disease_name":"Acquired arginine vasopressin deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001959","is_excluded":false,"label":"Polydipsia","onset_id":null,"reference":"ORPHA:95626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"206870b13eecdc5bb895b60a136b6dd82220d91d83723199f39c33d718207254","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:95626","disease_name":"Acquired arginine vasopressin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001824","is_excluded":false,"label":"Weight loss","onset_id":null,"reference":"ORPHA:95626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"39629a9570fed387d79afe4c863e70d4c60b219bb41f5496d5817aa0c780f1d2","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:95626","disease_name":"Acquired arginine vasopressin deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100515","is_excluded":false,"label":"Pollakisuria","onset_id":null,"reference":"ORPHA:95626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019846\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:95626</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Acquired central diabetes insipidus (acquired CDI) is a subtype of central diabetes insipidus (CDI), characterized by polyuria and polydipsia, due to an idiopathic or secondary decrease in vasopressin (AVP) production.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019846\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"acquired-central-diabetes-insipidus","sourceDocuments":[{"name":"MONDO: acquired central diabetes insipidus","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019846"}],"sourceNote":"","synonyms":["acquired CDI","acquired central diabetes insipidus","acquired neurogenic diabetes insipidus"],"takeawayHtml":"","title":"acquired central diabetes insipidus"},"schemaVersion":1}
